Insilico Details AI-Designed, Cancer-Fighting PROTAC Targeting PKMYT1
A 3D virtual model of the PKMYT1–PROTAC–CRBN ternary complex depicting how Insilico Medicine’s bifunctional proteolysis-targeting chimera (PROTAC) D16-M1P2 (shown in yellow) inhibits membrane-associated tyrosine-threonine protein kinase 1 (PKMYT1, shown in…









